These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11172955)

  • 1. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
    Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
    Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
    Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
    Ha CS; Lee MS; McLaughlin P; Tucker SL; Wilder RB; Cox JD; Cabanillas F
    Cancer J; 2004; 10(1):49-53. PubMed ID: 15000495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
    Ha CS; Tucker SL; Blanco AI; Wilder RB; McLaughlin P; Cabanillas F; Cox JD
    Cancer; 2001 Sep; 92(5):1074-9. PubMed ID: 11571717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
    Ha CS; Kong JS; Tucker SL; McLaughlin P; Wilder RB; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):316-20. PubMed ID: 12957240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
    Ha CS; Cabanillas F; Lee MS; Tucker SL; McLaughlin P; Rodriguez MA; Younes A; Romaguera JE; Mesina OM; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):188-93. PubMed ID: 16111588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
    López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
    Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
    Ha CS; Tucker SL; Blanco AI; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1207-12. PubMed ID: 10613314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
    Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
    J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
    Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
    Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma.
    Moos M; Schulz R; Martin S; Benner A; Haas R
    Leukemia; 1998 Dec; 12(12):1971-6. PubMed ID: 9844927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells.
    Pichert G; Schmitz SF; Hess U; Cerny T; Cogliatti SB; Betticher D; Stupp R; Schmitter D; Stahel RA; Ghielmini M
    Clin Lymphoma; 2001 Mar; 1(4):293-7. PubMed ID: 11707844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
    Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
    Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma.
    Finke J; Slanina J; Lange W; Dölken G
    J Clin Oncol; 1993 Sep; 11(9):1668-73. PubMed ID: 8355034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
    Tsimberidou AM; Jiang Y; Ford RJ; Lichtiger B; Medeiros LJ; McLaughlin P; Cabanillas F; Sarris AH
    Leuk Lymphoma; 2002 Aug; 43(8):1589-98. PubMed ID: 12400601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma.
    Panjan M; Boltezar L; Novakovic S; Kokovic I; Jezersek Novakovic B
    Radiol Oncol; 2023 Dec; 57(4):487-492. PubMed ID: 37439703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.